Molecular markers in early invasive oesophageal adenocarcinoma

Duration of the project

15.06.2017. - 15.12.2017.

Countries and institutions involved in the project

Riga Stradins University
University Hospital Cologne

Aim of the project

The general aim is to create solid basis for further development of scientific and pedagogical cooperation between University Hospital Cologne and Riga Stradins University. The scientific aim is to identify novel predictive biomarkers in early invasive oesophageal adenocarcinoma.

Main activities of the project

  1. Morphology-based research analysis of the cases (Riga Stradins University, Department of Pathology; University Hospital Cologne, Institute of Pathology);
  2. Molecular analysis (University Hospital Cologne, Institute of Pathology);
  3. Public activities (Riga Stradins University)

Target group and number of persons involved

Direct target group: 127 persons (the project team, the personnel of the Department of Pathology, medical students)

Indirect target group: the scientific community and students of Riga Stradins University; future patients with oesophageal cancer. The yearly number of oesophageal cancer cases reaches 137 in Latvia (2015), 5539 in Germany (2012) and 456’000 worldwide (2012).